SWP
DFTX

Strategic Wealth Partners’s Definium Therapeutics DFTX Stock Holding History

Strategic Wealth Partners’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.2K Buy
429
+263
+158% +$6.5K ﹤0.01% 745
2026
Q1 		$3.14K Hold
166
– – ﹤0.01% 1111
2025
Q4 		$2.22K Buy
+166
New +$2.05K ﹤0.01% 1186

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Strategic Wealth Partners's DFTX Position: Q2 2026 in Review

Strategic Wealth Partners increased its Definium Therapeutics (DFTX) stake by 158% in Q2 2026, buying an estimated $6.5K and bringing the position to 429 shares worth $20.2K. The position accounts for ﹤0.01% of the portfolio, ranked #745.

Strategic Wealth Partners first reported a position in DFTX in Q4 2025 and has held it in 3 quarters since. 361 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Strategic Wealth Partners held 429 shares of Definium Therapeutics worth $20.2K as of Q2 2026.
  • Strategic Wealth Partners bought 263 Definium Therapeutics shares in Q2 2026, an estimated $6.5K.
  • Definium Therapeutics made up ﹤0.01% of Strategic Wealth Partners's portfolio in Q2 2026, its #745 holding.
  • Strategic Wealth Partners first reported a position in Definium Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 361 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Strategic Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.